#prograf

Generic TACROLIMUS / Brand PROGRAF PROTOPIC 0.01% / 0.03% / 0.25mg / 0.5mg / 1mg / 2mg / 5mg Tube / Capsule / Tablet / Injection Vial is prescribed who have undergone a transplant for preventing organ rejection. Tacrolimus / Prograf Protopic medication is classified as an immunosuppressant. Tacrolimus / Prograf Protopic medicine suppresses the response of the immune system of the body thus helping the body in accepting the new transplanted organ like its own organ, in patients who have undergone transplantation. In allergic eye disease, Tacrolimus / Prograf Protopic drug acts by lowering the intensity of chemicals (like histamine), responsible for causing symptoms of allergic eye like swelling and redness.

Content Source - https://www.911globalmeds.com/buy-tacrolimus-prograf-protopic-online

Tacrolimus 0.25 mg Capsule (Generic of PROGRAF)

100 Capsules | US$ 88 US$ 80 | Save 9 % | Buy Now

200 Capsules | US$ 171 US$ 155 | Save 3 % + 9 % | Buy Now

400 Capsules | US$ 334 US$ 304 | Save 5 % + 9 % | Buy Now

800 Capsules | US$ 654 US$ 595 | Save 7 % + 9 % | Buy Now

Tacrolimus 0.5 mg Capsule (Generic of PROGRAF)

120 Capsules | US$ 139 US$ 126 | Save 9 % | Buy Now

240 Capsules | US$ 269 US$ 245 | Save 3 % + 9 % | Buy Now

480 Capsules | US$ 527 US$ 479 | Save 5 % + 9 % | Buy Now

960 Capsules | US$ 1031 US$ 938 | Save 7 % + 9 % | Buy Now

Tacrolimus 0.5 mg Capsule (Brand PROGRAF, Astellas)

100 Capsules | US$ 231 US$ 210 | Save 9 % | Buy Now

200 Capsules | US$ 452 US$ 412 | Save 2 % + 9 % | Buy Now

400 Capsules | US$ 895 US$ 815 | Save 3 % + 9 % | Buy Now

800 Capsules | US$ 1772 US$ 1613 | Save 4 % + 9 % | Buy Now

Tacrolimus 1 mg Capsule (Generic of PROGRAF)

120 Capsules | US$ 145 US$ 132 | Save 9 % | Buy Now

240 Capsules | US$ 281 US$ 256 | Save 3 % + 9 % | Buy Now

480 Capsules | US$ 551 US$ 502 | Save 5 % + 9 % | Buy Now

The in-use shelf-life of Prograf® (immediate-release tacrolimus) capsules once removed from the inner protective aluminium wrapper has changed from 12 months to three months. This change is in response to recent stability testing undertaken by the drug sponsor. The change was approved by the Therapeutic Goods Administration (TGA) in December 2021 and updated in the Australian Product Information and Consumer Medicine Information in March 2022. As the drug sponsor.

transitions to new packs, the TGA has permitted the continued use of Prograf packs with the 12 month in-use shelf-life printed on the box. However, use must comply to the new three month in-use shelf life. At the time of publication, no other brands of tacrolimus capsules (immediate or controlled release) are affected by this change.

Prograf is indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

Prograf is available in 0.5 mg, 1 mg and 5 mg capsules. They are supplied in blister strips of 10 capsules, packaged within an outer protective aluminium wrapper which reduces light exposure.

PROGRAF is a prescription medicine used with other medicines to help prevent organ rejection in people who have had a kidney, liver, or heart transplant and PROGRAF is not for use with medicines called cyclosporines (Gengraf®, Neoral®, and Sandimune®).

I am part for that group.

Brand Name: Astagraf, Prograf

Generic Available*

Common Dosage Forms:

Capsules (Prograf)*: 0.5 mg, 1 mg, 5 mg

Capsules, extended release (Astragraf XL): 0.5 mg, 1 mg, 5 mg

Granules (Prograf): 0.2 mg, 1 mg/packet

*Tacrolimus is also available in a topical ointment which is not covered on this card.

FDA Indications/Dosages:

For the prophylaxis of organ rejection in kidney and liver transplants: Start with 0.075-0.2 mg/kg/day given in two divided doses (Prograf) or 0.15-0.2 mg/kg/day in one dose (Astagraf XL). Whole blood concentrations should be in the range of 5-20 ng/mL. Dosages must be individualized and titrated based on clinical assessments of rejection and tolerability.

Monitor: Blood glucose, Drug trough levels

Pharmacology/Pharmacokinetics: Tacrolimus causes immunosuppression by inhibiting T-lymphocyte activation. It is postulated that it works by binding to an intracellular protein, FKBP-12, which forms a complex with calcium, calmodulin, and calcineurin. This complex inhibits the phosphatase activity of calcineurin which inhibits the dephosphorylation and translocation of nuclear factor of activated T-cells (NF-AT). Oral bioavailability is variable and is decreased when taken with food. Tacrolimus is 99% bound to plasma proteins. Metabolism occurs in the liver via CYP3A to activate and inactive metabolites.

Drug Interactions: Avoid the use of live vaccines during treatment. CYP3A inhibitors or substrates (ketoconazole, itraconazole, voriconazole, ritonavir, nelfinavir, verapamil, diltiazem, nifedipine, nicardipine, erythromycin, clarithromycin, troleandomycin, chloramphenicol, lansoprazole, omeprazole, bromocriptine, nefazodone, metoclopramide, danazol, ethinyl estradiol, cimetidine, and methyl prednisone) may increase plasma levels of tacrolimus. CYP3A inducers (phenytoin, phenobarbital, carbamazepine, St. John’s Wort, and rifampin) may decrease plasma levels of tacrolimus. Magnesium and aluminum hydroxide antacids may increase tacrolimus whole blood concentrations. Caution with use of other agents associated with hyperkalemia (potassium-sparing diuretics, ACEIs, and ARBs).

Contraindications/Precautions: Patients taking immunosuppressants are at an increased risk of developing lymphomas and malignancies, especially of the skin. Patients should protect themselves from sunlight and UV light. There is also an increased risk of bacterial, viral, protozoal, and fungal infections, sometimes serious in nature. Some cases of new onset diabetes mellitus have occurred in lever, heart, and kidney transplant patients taking tacrolimus. Use with caution in patients with hepatic impairment. Pregnancy Category C.

Adverse Effects: Most common adverse effects include infection, tremor, hypertension, constipation, diarrhea, headache, abdominal pain, insomnia, nausea, hypomagnesemia, UTI, hypophosphatemia, peripheral edema, asthenia, pain, hyperlipidemia, hyperkalemia, and anemia. Less common but serious adverse effects include nephrotoxicity, neurotoxicity, lymphomas, skin cancer, pure red cell aplasia, diabetes, and myocardial hypertrophy.

Patient Consultation:

Take each dose on an empty stomach – one hour before or two hours after a meal – unless otherwise directed.

It is important to be consistent with your doses. If a dose is missed, take it as soon as possible.

XL capsules must be taken whole.

Do not discontinue therapy without first consulting physician.

Avoid grapefruit or drinking grapefruit during treatment.

Avoid antacids containing magnesium, aluminum, cimetidine, lansoprazole, or omeprazole during treatment.

Avoid exposure to sunlight and UV light.

紙と印刷ラボ展ポスター

تعليمات ادوية زراعة الكلي

تعليمات ادوية زراعة الكلي – عندما يقوم مريض الفشل الكلوي باجراء زراعة كلي فانه يتحتم عليه العيش مع الادوية المهمة التي تقوم بتثبيط المناعة لعدم مقاومة الجسم للكلية المزروعة ,وتعتبر ادوية زراعة الكلي من الامور الاساسية الواجب للمريض تناولها بمواعيد منتظمة ثابته وعدم اهمالها باي شكل من الاشكال نظرا لانها تسبب الكثير من المشاكل التي من الممكن تخسر كليتك بسببها .. سنعرض تعليمات ادوية زراعة الكلي…